Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET) (Mild Cognitive Impairment and Alzheimer’s Disease)
ALZ-NET collects clinical and safety data about patients being evaluated for memory concerns or receiving new FDA-approved treatments for Alzheimer’s disease, including drugs/medications and devices, and tracks the long-term health outcomes associated with their use in real-world settings. ALZ-NET is a voluntary health care provider-enrolled patient network.
Inclusion Criteria:
Patient has a diagnosis of MCI or dementia with clinical suspicion of AD as contributing pathology and (1) is being evaluated for treatment or, (2) will be initiating treatment, or (3) has already initiated treatment with novel FDA-approved AD therapies in real-world clinical practice (full criteria in link below)
What to Expect
There is no charge to join ALZ-NET. ALZ-NET does not require additional effort on the patient or caregiver’s behalf other than routinely visiting your health care provider for your scheduled visits. Your health care provider is required to be located in a registered ALZ-NET site. Your provider will advise if you are eligible to participate in ALZ-NET.
For more information click the link below or contact Tiffany Hoefler at thoefler@dentinstitute.com or 716-961-9219